Consumption of medicines in high-risk pregnancy: evaluation of determinants related to the use of prescription drugs and self-medication

The use of drugs during pregnancy still represents a challenge for medicine, since the majority of drugs cross the placental barrier with a potential to cause several congenital problems to the fetus, and most of them have not been clinically tested in pregnant patients. At the same time, the medicalization phenomenon, self-medication, and lack of patient information about the misuse of medicines are additional problems. Thus, the aim of this study was to evaluate the pattern of medicine consumption in high-risk pregnancies and the determinants related to this consumption pattern. In order to do so, a cross-sectional descriptive study was performed with puerperal women who had a history of high-risk pregnancy. Statistically significant associations were found between self-medication and fewer prenatal visits, and cigarette use during pregnancy and a higher number of children. According to these data, the vulnerability of this population to the risks of drug use is evident, demonstrating a gap that requires urgent interventions in health-care education.O uso de medicamentos na gestação representa, ainda hoje, um desafio para a medicina, visto que grande parte dos fármacos atravessa a barreira placentária e, na maioria, não foi testada clinicamente em gestantes, podendo vir a ocasionar diversos problemas congênitos ao feto. Ao mesmo tempo, a automedicação, o fenômeno da medicalização e a falta de informação sobre os riscos do mau uso de medicamentos são problemas adicionais. Diante disto, o objetivo deste estudo consistiu em avaliar o padrão de consumo de medicamentos na gestação de alto risco e os determinantes relacionados ao seu padrão de consumo. Para tanto, realizou-se um estudo descritivo de corte transversal com puérperas, que apresentaram gestação de alto risco. Verificaram-se associações estatisticamente significativas entre automedicação e mulheres com menor número de consultas de pré-natal, uso de cigarro na gestação e maior número de filhos. De posse destes dados, fica evidente a vulnerabilidade dessa população aos riscos decorrentes do uso de medicamentos, sendo esta lacuna um campo de prática com necessidade de intervenções urgentes no âmbito da educação em saúde

Consumption of medicines in high-risk pregnancy: evaluation of determinants related to the use of prescription drugs and self-medication

The use of drugs during pregnancy still represents a challenge for medicine, since the majority of drugs cross the placental barrier with a potential to cause several congenital problems to the fetus, and most of them have not been clinically tested in pregnant patients. At the same time, the medicalization phenomenon, self-medication, and lack of patient information about the misuse of medicines are additional problems. Thus, the aim of this study was to evaluate the pattern of medicine consumption in high-risk pregnancies and the determinants related to this consumption pattern. In order to do so, a cross-sectional descriptive study was performed with puerperal women who had a history of high-risk pregnancy. Statistically significant associations were found between self-medication and fewer prenatal visits, and cigarette use during pregnancy and a higher number of children. According to these data, the vulnerability of this population to the risks of drug use is evident, demonstrating a gap that requires urgent interventions in health-care education

Accuracy of information on herbal medicines (phytoterapeutics agents) advertisements published in Paraíba, Brazil

Este estudo tem como objetivo avaliar a adequação legal da propaganda e publicidade de medicamentos fitoterápicos anunciada na Paraíba através de peças publicitárias obtidas na forma de impressos, os quais foram coletados em consultórios médicos, hospitais públicos e privados, farmácias e congressos. Verificou-se que as 53 propagandas coletadas promoveram 351 fitoterápicos, anunciando 140 plantas diferentes. A análise do material evidenciou irregularidades que ferem a legislação vigente: a RDC N° 102/2000 e a RDC N° 48/2004 da ANVISA (Agência Nacional de Vigilância Sanitária), regulamentadoras da propaganda de medicamentos e do registro de fitoterápicos respectivamente. A promoção de propagandas mais éticas para medicamentos é de interesse da ANVISA, além de ser extremamente importante para a população que é sempre a maior vítima das irregularidades.The aim of this study is to evaluate the advertisements accuracy of herbal medicines (phytoterapeutic agents) published in Paraíba through data obtained in the form of printed ads (leaflets) collected at medical clinics, public and private hospitals, drugstores and medical congress. It was verified that the 53 collected ads promoted 351 herbal medicines, announcing 140 different plants. The analysis of the ads evidenced irregularities according to Brazilian regulatory guidelines: RDC N° 102/2000 and RDC N° 48/2004, wich regulate advertisements and herbal medicines respectively. The promotion of more ethical ads for medicines is one the most important interest of the ANVISA (National Agency of Sanitary Surveillance), besides being an extremely important fact for the population that is always the largest victim of the irregularities.Colegio de Farmacéuticos de la Provincia de Buenos Aire

Accuracy of information on herbal medicines (phytoterapeutics agents) advertisements published in Paraíba, Brazil

Este estudo tem como objetivo avaliar a adequação legal da propaganda e publicidade de medicamentos fitoterápicos anunciada na Paraíba através de peças publicitárias obtidas na forma de impressos, os quais foram coletados em consultórios médicos, hospitais públicos e privados, farmácias e congressos. Verificou-se que as 53 propagandas coletadas promoveram 351 fitoterápicos, anunciando 140 plantas diferentes. A análise do material evidenciou irregularidades que ferem a legislação vigente: a RDC N° 102/2000 e a RDC N° 48/2004 da ANVISA (Agência Nacional de Vigilância Sanitária), regulamentadoras da propaganda de medicamentos e do registro de fitoterápicos respectivamente. A promoção de propagandas mais éticas para medicamentos é de interesse da ANVISA, além de ser extremamente importante para a população que é sempre a maior vítima das irregularidades.The aim of this study is to evaluate the advertisements accuracy of herbal medicines (phytoterapeutic agents) published in Paraíba through data obtained in the form of printed ads (leaflets) collected at medical clinics, public and private hospitals, drugstores and medical congress. It was verified that the 53 collected ads promoted 351 herbal medicines, announcing 140 different plants. The analysis of the ads evidenced irregularities according to Brazilian regulatory guidelines: RDC N° 102/2000 and RDC N° 48/2004, wich regulate advertisements and herbal medicines respectively. The promotion of more ethical ads for medicines is one the most important interest of the ANVISA (National Agency of Sanitary Surveillance), besides being an extremely important fact for the population that is always the largest victim of the irregularities.Colegio de Farmacéuticos de la Provincia de Buenos Aire